Chemotherapy-induced Neutropenia
📧 Sign up to get email alerts when something new happens for Chemotherapy-induced Neutropenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: G-CSF-Induced Bone Pain and Supportive Care Approaches
This Clinical Trial Update discusses strategies to manage G-CSF-induced bone pain and evaluates supportive care approaches in a completed tr…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Patient Preference Between a Prefilled Syringe or a Prefilled Pen Device for Administration of Pegfilgrastim
A completed clinical trial compared patient preferences between a prefilled syringe and a prefilled pen for administering pegfilgrastim.
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3 [Phase 3]
Phase 3 trial comparing Plinabulin to Pegfilgrastim in patients with solid tumors receiving docetaxel-based myelosuppressive chemotherapy ha…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2 [Phase 2]
Phase 2 trial comparing plinabulin to pegfilgrastim in patients with solid tumors receiving docetaxel-based chemotherapy for chemotherapy-in…
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel [Phase 3]
Phase 3 trial evaluating Neugranin in breast cancer patients receiving doxorubicin/docetaxel for chemotherapy-induced neutropenia has comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-02-03Clinical Trial Update: Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel [Phase 2, Phase 3]
Clinical trial update for Balugrastim (Neugranin) in breast cancer patients receiving doxorubicin/docetaxel; Phase 2/3 completed with result…
-
CLINICAL_TRIALS trial_result · 2022-10-21Clinical Trial Update: Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients [Phase 3]
Phase 3 clinical trial evaluating lithium for chemotherapy-induced neutropenia in breast cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma [Phase 2]
Phase 2 clinical trial update for Mecapegfilgrastim (PEG-G-CSF) as prophylaxis for chemotherapy-induced neutropenia in lymphoma patients.
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: Feasibility of Monitoring Health Data in Pediatric Patients Undergoing Chemotherapy
Completed feasibility trial evaluating monitoring of health data in pediatric patients undergoing chemotherapy.
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia [Phase 3]
Phase 3 trial update comparing plinabulin to pegfilgrastim for prevention of TAC-induced neutropenia in chemotherapy patients; current statu…
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients [Phase 4]
Phase 4 trial updating timing of granulocyte colony-stimulating factor (G-CSF) after chemotherapy in pediatric patients to assess outcomes.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Plinabulin iv Solution in Prevention of TAC Induced Neutropenia [Phase 2]
Phase 2 clinical trial update for Plinabulin intravenous solution in preventing TAC-induced neutropenia has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial update evaluating Granulocyte Colony Stimulating Factor for prevention of febrile neutropenia in epithelial ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients [Phase 2]
Phase 2 trial update for a recombinant human serum albumin/G-CSF fusion protein in breast cancer patients undergoing chemotherapy, completed…
-
CLINICAL_TRIALS trial_result · 2019-06-28Clinical Trial Update: Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life Study
A real-life study evaluating the biosimilar Nivestim® for preventing chemotherapy-induced neutropenia; the trial has been terminated with re…
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Real World Study of PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia
A real-world study evaluating PEG-rhG-CSF for the prevention of chemotherapy-induced neutropenia and associated myelosuppression.
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia [Phase 2]
A randomized Phase 2 trial comparing ANF-RHO to Neulasta for chemotherapy-induced neutropenia has been terminated. The study was a dose-find…
-
CLINICAL_TRIALS trial_result · 2019-01-07Clinical Trial Update: G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients [Phase 4]
Phase 4 trial update evaluating G-CSF for prevention of febrile neutropenia in gynecologic cancer patients undergoing chemotherapy.
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Pegteograstim in Children With Solid Tumors [Phase 2]
Phase 2 clinical trial update for Pegteograstim in pediatric patients with solid tumors undergoing chemotherapy.
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia [Phase 2]
Phase IIa trial results assess the efficacy and safety of Myelo001 for chemotherapy-induced neutropenia with completed status.
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Tolerability and Pharmacokinetics(PK)/Pharmacodynamics(PD) Study of GW003 in Healthy Subjects [Phase 1]
A Phase 1 trial evaluating tolerability and PK/PD of GW003 in healthy subjects, conducted to support chemotherapy-induced neutropenia treatm…
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients [Phase 1]
A Phase 1 study evaluating the safety and preliminary activity of an rHSA/GCSF fusion protein in breast cancer patients with chemotherapy-in…
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein [Phase 2]
Phase 2 study evaluating a recombinant human serum albumin–granulocyte colony-stimulating factor fusion protein for chemotherapy-induced neu…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim [Phase 3]
A Phase III trial comparing LA-EP2006 to pegfilgrastim in chemotherapy-induced neutropenia and breast cancer completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta® [Phase 3]
Phase III study comparing LA-EP2006 to Neulasta in preventing chemotherapy-induced neutropenia in breast cancer; the trial was completed and…